A practical evaluation of finite-sample BOIN calibration and Bayesian smoothing in phase I dose finding

We evaluated an asymmetric loss-based BOIN boundary and a monotone Bernstein estimator. The boundary preserved lookup-table operation but did not improve correct selection uniformly in seven monotone scenarios. It reduced overdose selection relative to BOIN, aBOIN, and gBOINS in six. Its accuracy depended on MTD position and overdose aversion. Bernstein selection reduced accuracy in most scenarios, especially for middle and high MTDs. Reference MCMC showed that importance-sampling error did not explain these losses. Target-based elimination eventually removes a repeatedly sampled MTD when toxicity exceeds the target. An upper-equivalence-bound threshold avoids this asymptotic conflict but not finite-sample elimination. Standard BOIN should remain the default. The loss-based boundary is justified only when the protocol prespecifies overdose avoidance and calibration shows an acceptable tradeoff. The Bernstein estimator is not recommended in its present form.

Authors

Publication Details

Journal
Figshare
Published
2026-11-14
DOI
https://doi.org/10.6084/m9.figshare.35012396
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A practical evaluation of finite-sample BOIN calibration and Bayesian smoothing in phase I dose finding

Siyi Chen
Figshare
Statistical Methods in Clinical Trials
article

A practical evaluation of finite-sample BOIN calibration and Bayesian smoothing in phase I dose finding

Siyi Chen
article en

Abstract

We evaluated an asymmetric loss-based BOIN boundary and a monotone Bernstein estimator. The boundary preserved lookup-table operation but did not improve correct selection uniformly in seven monotone scenarios. It reduced overdose selection relative to BOIN, aBOIN, and gBOINS in six. Its accuracy depended on MTD position and overdose aversion. Bernstein selection reduced accuracy in most scenarios, especially for middle and high MTDs. Reference MCMC showed that importance-sampling error did not explain these losses. Target-based elimination eventually removes a repeatedly sampled MTD when toxicity exceeds the target. An upper-equivalence-bound threshold avoids this asymptotic conflict but not finite-sample elimination. Standard BOIN should remain the default. The loss-based boundary is justified only when the protocol prespecifies overdose avoidance and calibration shows an acceptable tradeoff. The Bernstein estimator is not recommended in its present form.

Figshare
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon